RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DI MAIO M
Collezione AOU Novara

Items : 8

Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System. in JCO oncology practice / JCO Oncol Pract. 2024 Mar;20(3):438-447. doi: 10.1200/OP.23.00434. Epub 2024 Jan 11.

2024
AO Ordine Mauriziano
AOU Novara

Fazi P; Platzbecker U; Luppi M; Baron F; Di Maio M; Perrone F; Venditti A; Voso MT; Brini A; Cavo M; Anota A; Gaidano G; Giesinger JM; Sparano F; Vignetti M; Efficace F;

Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. in ESMO open / ESMO Open. 2022 Oct;7(5):100575. doi: 10.1016/j.esmoop.2022.100575. Epub 2022 Sep 22.

2022
AO Ordine Mauriziano
AOU Novara

Cattrini C; Mennitto A; Maiello E; Altavilla A; Messina C; Roviello G; De Giorgi U; Maiorano BA; Di Maio M;

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Russo A; Porzio G; Tiseo M; Russano M; Ficorella C; Addeo A; Banna GL; Friedlaender A; Spinelli GP; Metro G; Migliorino MR; Passiglia F; Ricciardi S; Zoratto F; Pecci F; Di Marino P; Mansueto G; De Tursi M; Tuzi A; Gori S; Della Gravara L; Macerelli M; Rastelli F; Chiari R; Gelibter A; Marchetti P; Antonuzzo L; Mazzoni F; et alii...

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Ficorella C; Addeo A; Friedlaender A; Banna GL; Di Maio M; Spinelli GP; Russo A; Adamo V; De Filippis M; Metro G; Simona C; Natalizio S; Migliorino MR; Landi L; Ricciardi S; Buti S; Minuti G; Nigro O; Cantini L; Bracarda S; Citarella F; Russano M; Filetti M; Zoratto F; Gori S; De Tursi M; Mansueto G; Rocco D; et alii...

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Cortellini A; Mazzaschi G; Tiseo M; Pinato DJ; Carmisciano L; Ficorella C; Porzio G; Cannita K; Friedlaender A; Addeo A; Banna GL; Spinelli GP; Adamo V; Russo A; Olmetto E; Metro G; Landi L; Ricciardi S; Migliorino MR; Tabbò F; Minuti G; Tuzi A; Bisonni R; Follador A; Gelibter A; Siringo M; Signorelli D; De Toma A; Garassino MC; et alii...

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. in Journal for immunotherapy of cancer / J Immunother Cancer. 2021 Apr;9(4):e002421. doi: 10.1136/jitc-2021-002421.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Ficorella C; Porzio G; Cannita K; Addeo A; Banna GL; Friedlaender A; Spinelli GP; Russo A; Adamo V; Metro G; Bironzo P; Passiglia F; Ricciardi S; Migliorino MR; Landi L; Minuti G; Tuzi A; Bordi P; Russano M; Cantini L; Santini D; Citarella F; Zoratto F; Filetti M; Mansueto G; Di Marino P; Grassadonia A; Inno A; et alii...

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Mar;22(3):294-301. doi: 10.1007/s12094-019-02222-8. Epub 2019 Oct 19.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Novello S; Di Maio M; Tiseo M; Galetta D; Bria E; Rossi G; Tabbò F; Cortinovis D; Rizzo P; Delmonte A; Bareggi C; Del Conte A; Sergi C; Casartelli C; Gregorc V; Graziano P; Rossi A; Maiello E; Scotti V; Martelli O; Borra G; Riccardi F; Osman G; Cappuzzo F; Cecere F; Pilotto S; Ghilardi L; Bordi P; Gobbini E; et alii...

Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes. in The American journal of cardiology / Am J Cardiol. 2018 Jul 1;122(1):61-68. doi: 10.1016/j.amjcard.2018.03.003. Epub 2018 Mar 27.

2018
AOU Novara

De Rosa R; Silverio A; Varricchio A; De Luca G; Di Maio M; Radano I; Belmonte M; De Angelis MC; Moscarella E; Citro R; Piscione F; Galasso G;